Maharashtra FDA mandates hospitals to let patients buy medicines from any licensed pharmacy, boosting consumer rights and...
pharma manufacturing
India's drug regulator increases price caps for essential cancer drugs cisplatin and carboplatin by 50% to combat...
Britain's MHRA approves Novo Nordisk's oral weight-loss drug, making the UK the first European market for this...
AstraZeneca's Enhertu receives Indian regulatory approval for first-line HER2-positive breast cancer treatment, offering a new therapeutic option.
India's drug pricing authority is reviewing essential cancer drug prices, including carboplatin and cisplatin, due to escalating...
Serum Institute of India partners with Oxford University to produce a new Ebola vaccine, backed by $8.6M...
Novartis' experimental actinium-based drug shows promising anti-tumor activity in prostate cancer patients, with higher response rates in...
Cipla aims for 40-50 global product filings in three years, focusing on innovation, complex generics, and biosimilars...
Zydus Therapeutics' saroglitazar receives US FDA priority review for primary biliary cholangitis, a rare liver disease. Potential...
Wockhardt's indigenously developed antibiotic, Zaynich, receives CDSCO approval for treating complicated urinary tract infections in adults, marking...